Garland nominated in two categories at the OBN BioSeed Awards

🎉 The good news keeps on coming!

We are delighted to announce that Garland is a finalist in not one but two categories at the upcoming BioSeed #obnAwards2025!

➡️ Best Early Stage Medtech Company Award
➡️ The BioSeed One to Watch Award

The BioSeed awards are highly regarded and sought-after awards programme for life sciences, designed to celebrate innovation and outstanding achievement across all corners of the industry. The twelve award categories shine a light on companies at all stages of development, recognising inspirational leadership, exciting innovation, novel and exciting approaches to unmet clinical needs, outstanding company progression and the delivery of real-life, tangible results.

The independent external judging panel will now evaluate each entry in a rigorous assessment process, with the winners announced at the awards ceremony in London on 26th November.

Thank you to OBN (UK) Ltd for recognising us…let’s go!

#maltahip #innovation #totalhipreplacement

https://www.linkedin.com/feed/update/urn:li:activity:7371478944958582784
Share the Post: